How many patents does
Aveo Pharmaceuticals have?
patents
286
families
33
granted
58
applications
228
US
65
EP
40
WO
35
CN
17
JP
14
KR
10
RoW
105
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Aveo Pharmaceuticals
Top ten assignees appearing on patents
2009 - 2018
| aveo pharmaceuticals | 252 |
| xoma technology | 31 |
| osi pharmaceuticals | 4 |
| biodesix | 3 |
2009
| aveo pharmaceuticals | 24 |
| xoma technology | 5 |
2018
| aveo pharmaceuticals | 11 |
| osi pharmaceuticals | 1 |
Aveo Pharmaceuticals
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| hepatocyte growth factor (hgf) binding proteins | 67 | 2006 |
| anti-erbb3 antibodies | 35 | 2010 |
| anti-fgfr2 antibodies | 19 | 2010 |
| anti-gdf15 antibodies | 18 | 2012 |
| predicting tumor response to anti-erbb3 antibodies | 17 | 2011 |
| anti-ron antibodies | 12 | 2010 |
| tivozanib and temsirolimus in combination | 11 | 2009 |
| tivozanib response prediction | 11 | 2009 |
| treatment of chronic kidney disease and other renal dysfunction using a gdf15 modulator | 9 | 2014 |
| tivozanib response prediction | 9 | 2009 |